➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Colorcon
Harvard Business School
AstraZeneca
Moodys
Merck
Baxter

Last Updated: February 25, 2021

DrugPatentWatch Database Preview

POTIGA Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

When do Potiga patents expire, and what generic alternatives are available?

Potiga is a drug marketed by Glaxosmithkline and is included in one NDA.

The generic ingredient in POTIGA is ezogabine. Additional details are available on the ezogabine profile page.

Drug patent expirations by year for POTIGA
Drug Prices for POTIGA

See drug prices for POTIGA

Recent Clinical Trials for POTIGA

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Baylor College of MedicinePhase 2
National Institute of Mental Health (NIMH)Phase 2
James MurroughPhase 2

See all POTIGA clinical trials

US Patents and Regulatory Information for POTIGA

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glaxosmithkline POTIGA ezogabine TABLET;ORAL 022345-001 Jun 10, 2011 DISCN Yes No   Start Trial   Start Trial   Start Trial
Glaxosmithkline POTIGA ezogabine TABLET;ORAL 022345-004 Jun 10, 2011 DISCN Yes No   Start Trial   Start Trial   Start Trial
Glaxosmithkline POTIGA ezogabine TABLET;ORAL 022345-002 Jun 10, 2011 DISCN Yes No   Start Trial   Start Trial   Start Trial
Glaxosmithkline POTIGA ezogabine TABLET;ORAL 022345-003 Jun 10, 2011 DISCN Yes No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Merck
Harvard Business School
Mallinckrodt
Moodys
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.